Leadership Overview
Hikma Pharmaceuticals has 7 executives leading key functions including information technology, regional operations, and financial oversight.
Driven by a commitment to improving health, Hikma Pharmaceuticals focuses on manufacturing branded and non-branded generic pharmaceutical products, impacting global healthcare access through its extensive product portfolio and strategic market presence.
Driven by a commitment to improving health, Hikma Pharmaceuticals focuses on manufacturing branded and non-branded generic pharmaceutical products, impacting global healthcare access through its extensive product portfolio and strategic market presence.
Leadership Roles at Hikma Pharmaceuticals
Mazen Darwazah - Executive Vice Chairman & Deputy Chief Executive Officer (MENA)
Mazen Darwazah, the Executive Vice Chairman & Deputy Chief Executive Officer (MENA) at Hikma Pharmaceuticals, spearheads strategic growth and operational oversight within the Middle East and North Africa region. This executive role involves driving market penetration and expanding Hikma's product offerings across key MENA territories. Mazen Darwazah ensures alignment between regional business objectives and the company's overarching global strategy. By fostering strong stakeholder relationships and identifying new market opportunities, the Executive Vice Chairman & Deputy Chief Executive Officer (MENA) significantly contributes to Hikma's regional success. This leadership position is critical for navigating complex market dynamics and securing sustained revenue growth in the MENA landscape.
Ala'a Habboub - Chief Financial Officer (Jordan)
Ala'a Habboub, the Chief Financial Officer (Jordan) at Hikma Pharmaceuticals, manages the financial operations and strategic fiscal planning for the Jordanian market. This role involves overseeing budgeting, financial reporting, and capital allocation to support local business objectives. Ala'a Habboub ensures compliance with all financial regulations and drives fiscal discipline across the Jordanian operations. By providing critical financial insights, the Chief Financial Officer (Jordan) enables informed decision-making and supports sustainable growth within the region. This executive's expertise is vital for maintaining financial health and optimizing resource utilization in a key operational hub.

Areb Kurdi - Acting Chief Financial Officer
Areb Kurdi, the Acting Chief Financial Officer at Hikma Pharmaceuticals, provides interim financial leadership and strategic guidance. This critical role involves overseeing the company's financial health, managing fiscal operations, and ensuring robust financial reporting during a transitional period. Areb Kurdi directs efforts to maintain financial stability and support ongoing business objectives. By collaborating with executive leadership, the Acting Chief Financial Officer ensures continuity in financial planning and execution. This position is essential for navigating financial complexities and upholding Hikma's commitment to fiscal responsibility and strategic investment.
Tareq Darwazeh - Chief Operating Officer (MENA Region)
Tareq Darwazeh, the Chief Operating Officer (MENA Region) at Hikma Pharmaceuticals, directs the operational execution and efficiency across the Middle East and North Africa. This executive role focuses on optimizing supply chains, manufacturing processes, and distribution networks to meet regional demand. Tareq Darwazeh ensures seamless integration of operations with market strategies, driving productivity and cost-effectiveness. By overseeing day-to-day activities, the Chief Operating Officer (MENA Region) guarantees the reliable delivery of Hikma's pharmaceutical products. This leadership position is fundamental to achieving operational excellence and supporting the company's expansion goals in these vital markets.
Patricia Bousfield - Chief Information Officer
Patricia Bousfield, the Chief Information Officer at Hikma Pharmaceuticals, directs the company's global technology strategy and digital transformation initiatives. Overseeing all IT infrastructure, Bousfield ensures robust cybersecurity measures and data integrity across all operational platforms. This leadership role involves architecting scalable technology solutions that support Hikma's expanding product lines and market reach. By optimizing enterprise systems, Patricia Bousfield drives operational efficiency and enhances the company's competitive edge in the pharmaceutical sector. The Chief Information Officer's focus remains on leveraging technology to streamline processes and foster innovation throughout the organization.
Bassam Kanaan - Executive VP, Corporate Development Mergers & Acquisitions
Bassam Kanaan, the Executive VP, Corporate Development Mergers & Acquisitions at Hikma Pharmaceuticals, leads strategic initiatives for business expansion through acquisitions and partnerships. This executive role involves identifying, evaluating, and executing merger and acquisition opportunities that align with Hikma's growth objectives. Bassam Kanaan manages the due diligence process and negotiates deal structures to maximize value for the company. By driving strategic corporate development, the Executive VP, Corporate Development Mergers & Acquisitions plays a pivotal part in shaping Hikma's future market position. This leadership function is crucial for inorganic growth and enhancing the company's global footprint.
Chawki Sabri - Finnance
Chawki Sabri, the Finnance at Hikma Pharmaceuticals, contributes to the company's financial strategy and management. This role involves supporting financial planning, analysis, and reporting functions to ensure fiscal accuracy and efficiency. Chawki Sabri works to optimize financial processes and contribute to the company's overall economic health. By providing essential financial support, the Finnance role aids in strategic decision-making and resource allocation. This position is integral to maintaining the financial integrity and operational stability of Hikma Pharmaceuticals.
Explore Leadership Teams in Manufacturing
Zydus is a global pharmaceutical company headquartered in Ahmedabad, India. Founded in 1952, the company operates manufacturing sites and research facilities across multiple states in India as well as in the United States and Brazil. Zydus specializes in developing, manufacturing, and distributing pharmaceutical products with a significant global footprint. The company maintains a strong presence in regulated markets including the United States, Europe, Latin America, and South Africa, while also serving numerous emerging markets worldwide. Zydus offers a comprehensive portfolio of pharmaceutical products and services, supported by extensive research and development capabilities.
Company Leadership HW
AB
TS
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases.
Company Leadership
CA
SH
ST
Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.
Company Leadership SG
PC
MH
MO
Grupo NC is a leading Brazilian pharmaceutical company with roots dating back to 2014 when it began as a small pharmacy in Santo André. Officially founded in 1964 with its first factory in São Bernardo do Campo, the company has grown to become one of the largest pharmaceutical industries in Brazil. Grupo NC operates with a dual business model serving both B2B and B2C markets, offering innovative healthcare solutions and pharmacy retail services. The company maintains a strong presence in South America, particularly Brazil, while also expanding into Asian markets. Grupo NC is committed to sustainable development, innovation in healthcare solutions, and excellence in all operational aspects. The company's core values emphasize continuous improvement, responsible innovation, and making a positive impact in the markets where they operate.
Company Leadership ND
DM